Research and Development

Sanofi’s anti-cholestrol drug Kynamro has been recommended by an FDA committee, paving the way for US approval early next year. …

GPCR drug discovery firm Heptares Therapeutics has elected Dr Roger Perlmutter, the former executive VP, Research and Development, at Amgen …

Imagine you are investing £3.4 billion in changing your business, half of it in business-critical projects such as drug supply …

Abbott has terminated its Phase III trial of bardoxolone methyl in patients with kidney disease and diabetes after concerns over …

Specialty pharma firm AP Pharma has announced the appointment of Robert Rosen as senior vice president and chief commercial officer. …

Amgen has announced the appointment of Cynthia Patton to senior vice president and chief compliance officer. Patton will report to …

The issue of gender balance within UK boards has moved quickly up the business agenda following last year’s Davies Report. …

Merck has gained access to AiCuris’ portfolio of investigational medicines targeting human cytomegalovirus (HCMV) via a global licensing agreement. It …

A round-up of news in the contract research sector, including new contracts for Medpace, Particle Sciences and PRC Clinical, another …

Roche and Eli Lilly are providing drugs free of charge to US investigators conducting a worldwide trial of Alzheimer’s disease …

India’s clinical trials industry is facing a crisis because of growing concerns about unethical or illegal practices in the sector. …

The BioIndustry Association (BIA) has said it welcomes the appointment of UK MEP Glenis Willmott as the rapporteur for the …

The Publicis Healthcare Communications Group (PHCG) has appointed Adrian Sansone as managing director, Publicis Life Brands Medicus (PLBM). PLBM is …

GlaxoSmithKline Vaccines has signed a deal with US not-for-profit biotech Aeras to develop a new vaccine which will treat tuberculosis …

Targacept is to make 38% of its staff redundant and cease laboratory operations by the end of the year as …